0.00Open0.00Pre Close0 Volume0 Open Interest141.00Strike Price0.00Turnover0.00%IV-3.83%PremiumDec 13, 2024Expiry Date5.62Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma28.20Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Millaai : Are you being trapped and looking for a rescuer everywhere?
Growth Investor27 : Good info, NEXLIZET is a great drug, my brother takes it. ESPR stock is undervalued, should be above $5
Growth Investor27 Millaai : The author has been buying below $2 so your comment is off. This research article has all the due diligence to see, other than the fact Institutions have been heavly buying this year, fintel shows now 74% owned. ESPR is a good investment.
104248191 : please f o